Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials
2012; Public Library of Science; Volume: 9; Issue: 4 Linguagem: Inglês
10.1371/journal.pmed.1001204
ISSN1549-1676
AutoresRémy Boussageon, Irène Supper, Théodora Bejan‐Angoulvant, Nadir Kellou, Michel Cucherat, Jean‐Pierre Boissel, Behrouz Kassaï, Alain Moreau, François Gueyffier, Catherine Cornu,
Tópico(s)Diabetes Management and Research
ResumoCatherine Cornu and colleagues performed a meta-analysis of randomised controlled trials of metformin efficacy on cardiovascular morbidity or mortality in patients with type 2 diabetes and showed that although metformin is considered the gold standard, its benefit/risk ratio remains uncertain.
Referência(s)